hypothalamic obesity


Also found in: Dictionary, Thesaurus, Encyclopedia.
Related to hypothalamic obesity: hypothalamus

hy·po·tha·lam·ic o·be·si·ty

obesity caused by disease of the hypothalamus.

hypothalamic obesity

Obesity resulting from dysfunction of the hypothalamus, esp. the appetite-regulating center.
See also: obesity
Mentioned in ?
References in periodicals archive ?
Reportedly, the purpose of this study is to investigate the overall safety and tolerability as well as effect on satiety, appetite and weight loss of Tesomet in patients with hypothalamic obesity.
Saniona reports on recruitment of first hypothalamic obesity patients in phase 2a clinical study of Tesomet
Hypothalamic obesity is a major and unsolved problem in patients with hypothalamic lesions and has a major negative impact on survival and quality of life (23).
Duodenal-jejunal bypass normalizes pancreatic islet proliferation rate and function but not hepatic steatosis in hypothalamic obese rats
GLP1RA have been studied in both euglycaemic and diabetic patients with moderate to severe hypothalamic obesity. Over a period of up to 51 months, 8 out of 9 patients experienced substantial weight loss ranging from 9 to 22 kg (mean-13.1 5.1 kg), with improved insulin sensitivity and glycaemic control.
Endocrine and metabolic effects of Glucagon like peptide 1 receptor agonists (GLP1RA)
Spinedi, "Glucocorticoid-dependency of increased adiposity in a model of hypothalamic obesity," Neuroendocrinology Letters, vol.
Chronic glucocorticoid-rich milieu and liver dysfunction
Weight gain in craniopharyngioma--A model for hypothalamic obesity. Journal of Pediatric Endocrinology and Metabolism, 19(2), 121-127.
Health status in long-term survivors of pediatric craniopharyngiomas
Biotechnology company Saniona AB (STO:SANION) announced on Monday that it plans to initiate a clinical phase 2a study in the rare eating disorder hypothalamic obesity with its lead product Tesomet.
Saniona plans initiation of a phase 2a study with Tesomet for treatment of hypothalamic obesity
Las Vegas -- Sibutramine (Meridia), an adult diet drug, can help control the weight of children with hypothalamic obesity and other syndromes that make behavioral interventions ineffective, results from a small, double-blind, placebo-controlled trial suggest.
Sibutramine may help children with hypothalmic disorders lose weight
M2 EQUITYBITES-June 11, 2018-Saniona plans Phase 2a study for hypothalamic obesity treatment
Saniona plans Phase 2a study for hypothalamic obesity treatment
M2 PHARMA-June 11, 2018-Saniona plans Phase 2a study for hypothalamic obesity treatment
Saniona plans Phase 2a study for hypothalamic obesity treatment

Medical browser ?
Full browser ?